Literature DB >> 31834549

Profiling of differentially expressed circular RNAs in peripheral blood mononuclear cells from Alzheimer's disease patients.

Yanxin Li1, Zhanyun Lv2,3, Jing Zhang2,3, Qianqian Ma2,3, Qiuhua Li2,3, Li Song2,3, Li Gong2,3, Yunliang Zhu2,3, Xiangyuan Li2,3, Yanlei Hao4,5, Yan Yang6,7.   

Abstract

Expression of circular RNA (circRNA), a class of noncoding RNAs that regulates gene expression, is altered in Alzheimer's disease. This study profiled differentially expressed circRNAs in peripheral blood mononuclear cells (PBMCs) from five patients with Alzheimer's disease compared to healthy controls using circRNA microarrays. We identified a total of 4060 differentially expressed circRNAs (1990 upregulated and 2070 downregulated) in Alzheimer's disease patients. Among these circRNAs, 10 randomly selected circRNAs were verified using qRT-PCR. The top 10 upregulated and downregulated circRNAs were used to predict their target miRNAs. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses revealed that these differentially expressed circRNAs were strongly associated with inflammation, metabolism, and immune responses, which are all risk factors for Alzheimer's disease. The circRNA-miRNA-mRNA network was most involved in the MAPK, mTOR, AMPK, and WNT signaling pathways in Alzheimer's disease. In conclusion, the current study demonstrated the importance of circRNAs in Alzheimer's disease development. Future studies will evaluate some of these circRNAs as biomarkers for early disease detection and to develop therapeutic strategies to clinically control Alzheimer's disease progression.

Entities:  

Keywords:  Alzheimer’s disease; Circular RNAs; Microarray; microRNAs

Mesh:

Substances:

Year:  2019        PMID: 31834549     DOI: 10.1007/s11011-019-00497-y

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  45 in total

Review 1.  Wnt signaling: role in Alzheimer disease and schizophrenia.

Authors:  Nibaldo C Inestrosa; Carla Montecinos-Oliva; Marco Fuenzalida
Journal:  J Neuroimmune Pharmacol       Date:  2012-11-18       Impact factor: 4.147

2.  In vivo activation of Wnt signaling pathway enhances cognitive function of adult mice and reverses cognitive deficits in an Alzheimer's disease model.

Authors:  Jessica Y Vargas; Marco Fuenzalida; Nibaldo C Inestrosa
Journal:  J Neurosci       Date:  2014-02-05       Impact factor: 6.167

Review 3.  Epigenomics of Alzheimer's disease.

Authors:  David A Bennett; Lei Yu; Jingyun Yang; Gyan P Srivastava; Cristin Aubin; Philip L De Jager
Journal:  Transl Res       Date:  2014-05-16       Impact factor: 7.012

4.  Dynamic expression of de novo DNA methyltransferases Dnmt3a and Dnmt3b in the central nervous system.

Authors:  Jian Feng; Hua Chang; En Li; Guoping Fan
Journal:  J Neurosci Res       Date:  2005-03-15       Impact factor: 4.164

Review 5.  Genetics of the epilepsies: where are we and where are we going?

Authors:  Ingo Helbig; Daniel H Lowenstein
Journal:  Curr Opin Neurol       Date:  2013-04       Impact factor: 5.710

6.  Genetic regulatory network analysis for app based on genetical genomics approach.

Authors:  Xusheng Wang; Ying Chen; Xiaodong Wang; Lu Lu
Journal:  Exp Aging Res       Date:  2010 Jan-Mar       Impact factor: 1.645

7.  Silencing of miR155 promotes the production of inflammatory mediators in Guillain-Barré syndrome in vitro.

Authors:  Yu-Zhong Wang; Xun-Gang Feng; Qi-Guang Shi; Yan-Lei Hao; Yan Yang; Ai-Mei Zhang; Qing-Xia Kong
Journal:  Inflammation       Date:  2013-04       Impact factor: 4.092

8.  Natural RNA circles function as efficient microRNA sponges.

Authors:  Thomas B Hansen; Trine I Jensen; Bettina H Clausen; Jesper B Bramsen; Bente Finsen; Christian K Damgaard; Jørgen Kjems
Journal:  Nature       Date:  2013-02-27       Impact factor: 49.962

Review 9.  Progress in genome-wide association studies of schizophrenia in Han Chinese populations.

Authors:  Weihua Yue; Xin Yu; Dai Zhang
Journal:  NPJ Schizophr       Date:  2017-08-10

10.  MicroRNA-455-3p as a Potential Biomarker for Alzheimer's Disease: An Update.

Authors:  Subodh Kumar; P Hemachandra Reddy
Journal:  Front Aging Neurosci       Date:  2018-02-23       Impact factor: 5.750

View more
  6 in total

1.  Analysis of Changes of Intestinal Flora in Elderly Patients with Alzheimer's Disease and Liver Cancer and Its Correlation with Abnormal Gastrointestinal Motility.

Authors:  Weiwei Zhang; Xuelian Zhang; Yanyan Zhang; Huanyu Wu; Qiaoling Liu; Xinyu Zhou; Yunxia Meng
Journal:  J Oncol       Date:  2021-08-13       Impact factor: 4.375

2.  circUBAP2 regulates osteosarcoma progression via the miR‑204‑3p/HMGA2 axis.

Authors:  Weiguo Ma; Ning Xue; Junhua Zhang; Dan Wang; Xiaobin Yao; Lin Lin; Qingxia Xu
Journal:  Int J Oncol       Date:  2021-01-27       Impact factor: 5.650

Review 3.  CircRNAs: role in human diseases and potential use as biomarkers.

Authors:  Lorena Verduci; Emilio Tarcitano; Sabrina Strano; Yosef Yarden; Giovanni Blandino
Journal:  Cell Death Dis       Date:  2021-05-11       Impact factor: 8.469

Review 4.  Insights into the multifaceted role of circular RNAs: implications for Parkinson's disease pathogenesis and diagnosis.

Authors:  Epaminondas Doxakis
Journal:  NPJ Parkinsons Dis       Date:  2022-01-10

5.  A circular RNA blood panel that differentiates Alzheimer's disease from other dementia types.

Authors:  Ziye Ren; Changbiao Chu; Yana Pang; Huimin Cai; Longfei Jia
Journal:  Biomark Res       Date:  2022-08-18

Review 6.  The Emerging Role of Circular RNAs in Alzheimer's Disease and Parkinson's Disease.

Authors:  Meng Zhang; Zhigang Bian
Journal:  Front Aging Neurosci       Date:  2021-07-12       Impact factor: 5.750

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.